{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:03:07Z","timestamp":1771070587450,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360586"],"award-info":[{"award-number":["82360586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["Qiankeheji [2020] 1Z06"],"award-info":[{"award-number":["Qiankeheji [2020] 1Z06"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05403-y","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:26:03Z","timestamp":1760527563000},"page":"369-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of LSD1 enhances T cells anti-tumor immunity by promoting TNFSF14 expression in gastric cancer"],"prefix":"10.1007","volume":"481","author":[{"given":"Xueqing","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"3","key":"5403_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"5403_CR2","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3748\/wjg.v24.i24.2567","volume":"24","author":"J-P Gao","year":"2018","unstructured":"Gao J-P, Wei Xu, Liu W-T et al (2018) Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell. World J Gastroenterol 24(24):2567\u20132581","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5403_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG (2021) Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Ann Rev Pathol Mech Dis 16(1):223\u2013249","journal-title":"Ann Rev Pathol Mech Dis"},{"key":"5403_CR4","doi-asserted-by":"publisher","first-page":"216182","DOI":"10.1016\/j.canlet.2023.216182","volume":"562","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhang C, Wang H (2023) Immune-checkpoint inhibitor resistance in cancer treatment: current progress and future directions. Cancer Lett 562:216182","journal-title":"Cancer Lett"},{"issue":"2","key":"5403_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/bfgp\/ely019","volume":"18","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Cao L, Guan L et al (2019) Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics 18(2):107\u2013112","journal-title":"Brief Funct Genomics"},{"issue":"1","key":"5403_CR6","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1186\/s12943-021-01464-x","volume":"20","author":"E Dai","year":"2021","unstructured":"Dai E, Zhu Z, Wahed S et al (2021) Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer 20(1):021\u201301464","journal-title":"Mol Cancer"},{"key":"5403_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2021.06.022","volume":"83","author":"DM Avella","year":"2022","unstructured":"Avella DM, Patino VR, Suvilesh KN et al (2022) Epigenetic regulation of cancer immune cells. Semin Cancer Biol 83:377\u2013383","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"5403_CR8","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.trecan.2020.02.003","volume":"6","author":"J Cao","year":"2020","unstructured":"Cao J, Yan Q (2020) Cancer epigenetics, tumor immunity, and immunotherapy. Trends Cancer 6(7):580\u2013592","journal-title":"Trends Cancer"},{"issue":"5","key":"5403_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.bpj.2013.01.019","volume":"104","author":"NP Nurse","year":"2013","unstructured":"Nurse NP, Jimenez-Useche I, Smith IT, Yuan C (2013) Clipping of flexible tails of histones H3 and H4 affects the structure and dynamics of the nucleosome. Biophys J 104(5):1081\u20131088","journal-title":"Biophys J"},{"issue":"8","key":"5403_CR10","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1093\/nar\/gkab180","volume":"49","author":"S Pinter","year":"2021","unstructured":"Pinter S, Knodel F, Choudalakis M et al (2021) A functional LSD1 coregulator screen reveals a novel transcriptional regulatory. Nucleic Acids Res 49(8):4350\u20134370","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"5403_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.7150\/thno.66142","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ruan X, Li Y, Zhi J, Hu L, Hou X, Shi X, Wang X, Wang J, Ma W, Gu P (2022) KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt\/\u03b2-catenin signaling pathway. Theranostics 12(4):1500","journal-title":"Theranostics"},{"issue":"6","key":"5403_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.molcel.2005.08.027","volume":"19","author":"Y-J Shi","year":"2005","unstructured":"Shi Y-J, Matson C, Lan F et al (2005) Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19(6):857\u2013864","journal-title":"Mol Cell"},{"issue":"7057","key":"5403_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature04020","volume":"437","author":"E Metzger","year":"2005","unstructured":"Metzger E, Wissmann M, Yin Na et al (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent. Nature 437(7057):436\u2013439","journal-title":"Nature"},{"issue":"7138","key":"5403_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature05671","volume":"446","author":"J Wang","year":"2007","unstructured":"Wang J, Scully K, Zhu X et al (2007) Opposing LSD1 complexes function in developmental gene activation and repression. Nature 446(7138):882\u2013887","journal-title":"Nature"},{"issue":"8","key":"5403_CR15","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.celrep.2017.01.078","volume":"18","author":"I Scionti","year":"2017","unstructured":"Scionti I, Hayashi S, Mouradian S et al (2017) LSD1 controls timely MyoD expression via MyoD core enhancer transcription. Cell Rep 18(8):1996\u20132006","journal-title":"Cell Rep"},{"issue":"3","key":"5403_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"W Sheng","year":"2018","unstructured":"Sheng W, LaFleur MW, Nguyen TH et al (2018) LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell 174(3):549\u2013563","journal-title":"Cell"},{"issue":"8","key":"5403_CR17","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1158\/2159-8290.CD-20-0017","volume":"11","author":"W Sheng","year":"2021","unstructured":"Sheng W, Liu Yi, Chakraborty D et al (2021) Simultaneous inhibition of LSD1 and TGF\u03b2 enables eradication of poorly. Cancer Discov 11(8):1970\u20131981","journal-title":"Cancer Discov"},{"issue":"8","key":"5403_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.202050922","volume":"22","author":"LJ Zhao","year":"2021","unstructured":"Zhao LJ, Li YY, Zhang YT et al (2021) Lysine demethylase LSD1 delivered via small extracellular vesicles promotes. EMBO Rep 22(8):1","journal-title":"EMBO Rep"},{"key":"5403_CR19","doi-asserted-by":"publisher","first-page":"104991","DOI":"10.1016\/j.phrs.2020.104991","volume":"159","author":"LJ Zhao","year":"2020","unstructured":"Zhao LJ, Fan QQ, Li YY et al (2020) LSD1 deletion represses gastric cancer migration by upregulating a novel. Pharmacol Res 159:104991","journal-title":"Pharmacol Res"},{"key":"5403_CR20","doi-asserted-by":"publisher","first-page":"115684","DOI":"10.1016\/j.ejmech.2023.115684","volume":"259","author":"XJ Dai","year":"2023","unstructured":"Dai XJ, Liu Y, Wang N et al (2023) Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer. Eur J Med Chem 259:115684","journal-title":"Eur J Med Chem"},{"issue":"18","key":"5403_CR21","doi-asserted-by":"publisher","first-page":"16165","DOI":"10.1021\/acs.jmedchem.4c00972","volume":"67","author":"Bo Wang","year":"2024","unstructured":"Wang Bo, Wang S-W, Zhou Y et al (2024) Discovery of 2-aryl-4-aminoquinazolin-based LSD1 inhibitors to activate immune. J Med Chem 67(18):16165\u201316184","journal-title":"J Med Chem"},{"issue":"9","key":"5403_CR22","doi-asserted-by":"publisher","first-page":"9260","DOI":"10.1021\/acs.jmedchem.4c02851","volume":"68","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang Y, Geng Y et al (2025) The exploration of Indole-based LSD1-targeted inhibitors for enhanced immune. J Med Chem 68(9):9260\u20139278","journal-title":"J Med Chem"},{"issue":"6","key":"5403_CR23","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1021\/acs.jmedchem.2c01593","volume":"66","author":"X-J Dai","year":"2023","unstructured":"Dai X-J, Zhao L-J, Yang L-H et al (2023) Phenothiazine-based LSD1 inhibitor promotes T-cell killing response of gastric. J Med Chem 66(6):3896\u20133916","journal-title":"J Med Chem"},{"key":"5403_CR24","doi-asserted-by":"publisher","first-page":"115255","DOI":"10.1016\/j.ejmech.2023.115255","volume":"251","author":"HM Liu","year":"2023","unstructured":"Liu HM, Xiong XP, Jiang-Wan W et al (2023) Discovery of acridine-based LSD1 inhibitors as immune activators targeting LSD1. Eur J Med Chem 251:115255","journal-title":"Eur J Med Chem"},{"key":"5403_CR25","doi-asserted-by":"publisher","first-page":"115228","DOI":"10.1016\/j.ejmech.2023.115228","volume":"251","author":"QS Ma","year":"2023","unstructured":"Ma QS, Zhang YF, Li CY et al (2023) Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment. Eur J Med Chem 251:115228","journal-title":"Eur J Med Chem"},{"issue":"1","key":"5403_CR26","doi-asserted-by":"publisher","first-page":"022","DOI":"10.1186\/s12943-022-01557-1","volume":"21","author":"D-D Shen","year":"2022","unstructured":"Shen D-D, Pang J-R, Bi Y-P et al (2022) LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric. Mol Cancer 21(1):022\u201301557","journal-title":"Mol Cancer"},{"issue":"1","key":"5403_CR27","doi-asserted-by":"publisher","first-page":"023","DOI":"10.1186\/s12929-023-00952-0","volume":"30","author":"MAA Mamun","year":"2023","unstructured":"Mamun MAA, Zhang Y, Jin-Yuan Z et al (2023) LSD1: an emerging face in altering the tumor microenvironment and enhancing. J Biomed Sci 30(1):023\u201300952","journal-title":"J Biomed Sci"},{"issue":"2","key":"5403_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heliyon.2024.e24457","volume":"10","author":"X Xueqing","year":"2024","unstructured":"Xueqing X, Yongcan P, Wei L et al (2024) Regulation of T cells in the tumor microenvironment by histone methylation: LSD1. Heliyon 10(2):1","journal-title":"Heliyon"},{"key":"5403_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fimmu.2020.00922","volume":"11","author":"JG Skeate","year":"2020","unstructured":"Skeate JG, Otsmaa ME, Prins R et al (2020) TNFSF14: LIGHTing the way for effective cancer immunotherapy. Front Immunol 11:922","journal-title":"Front Immunol"},{"issue":"1","key":"5403_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","volume":"8","author":"DN Mauri","year":"1998","unstructured":"Mauri DN, Ebner R, Montgomery RI et al (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for. Immunity 8(1):21\u201330","journal-title":"Immunity"},{"issue":"12","key":"5403_CR31","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1172\/JCI200113827","volume":"108","author":"J Wang","year":"2001","unstructured":"Wang J, Lo JC, Foster A, Yu P et al (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 108(12):1771\u20131780","journal-title":"J Clin Invest"},{"issue":"9","key":"5403_CR32","first-page":"1","volume":"9","author":"A Bruce Lyons","year":"2013","unstructured":"Bruce Lyons A, Blake SJ, Doherty KV (2013) Flow cytometric analysis of cell division by dilution of CFSE and related dyes. Curr Protoc Cytom 9(9):1\u20139","journal-title":"Curr Protoc Cytom"},{"issue":"1","key":"5403_CR33","doi-asserted-by":"publisher","first-page":"023","DOI":"10.1186\/s12943-023-01885-w","volume":"22","author":"M Yi","year":"2023","unstructured":"Yi M, Li T, Niu M et al (2023) Exploiting innate immunity for cancer immunotherapy. Mol Cancer 22(1):023\u201301885","journal-title":"Mol Cancer"},{"issue":"1","key":"5403_CR34","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1186\/s12929-021-00737-3","volume":"28","author":"D Kim","year":"2021","unstructured":"Kim D, Kim KI, Baek SH (2021) Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases. J Biomed Sci 28(1):021\u201300737","journal-title":"J Biomed Sci"},{"issue":"9","key":"5403_CR35","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/1759-7714.13593","volume":"11","author":"Gu Chunrong","year":"2020","unstructured":"Chunrong Gu, Luo Y, Zhang S et al (2020) MAb NJ001 inhibits lung adenocarcinoma invasiveness by directly regulating TIMP-3. Thorac Cancer 11(9):2630\u20132638","journal-title":"Thorac Cancer"},{"key":"5403_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbrc.2021.04.028","volume":"557","author":"X Chen","year":"2021","unstructured":"Chen X, Liu C, Ji Le et al (2021) The circACC1\/miR-29c-3p\/FOXP1 network plays a key role in gastric cancer by. Biochem Biophys Res Commun 557:221\u2013227","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5403_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jcsm.12666","volume":"12","author":"D Neyroud","year":"2021","unstructured":"Neyroud D, Nosacka RL, Callaway CS et al (2021) FoxP1 is a transcriptional repressor associated with cancer cachexia that induces. J Cachexia Sarcopenia Muscle 12(2):421\u2013442","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"5403_CR38","doi-asserted-by":"publisher","first-page":"1113367","DOI":"10.1080\/2162402X.2015.1113367","volume":"5","author":"B Dharmadhikari","year":"2015","unstructured":"Dharmadhikari B, Meihui Wu, Abdullah NS et al (2015) CD137 and CD137L signals are main drivers of type 1, cell-mediated immune. Oncoimmunology 5(4):1113367","journal-title":"Oncoimmunology"},{"issue":"11","key":"5403_CR39","doi-asserted-by":"publisher","first-page":"e26859","DOI":"10.4161\/onci.26859","volume":"2","author":"Z Harfuddin","year":"2013","unstructured":"Harfuddin Z, Kwajah S, Sim ACN et al (2013) CD137L-stimulated dendritic cells are more potent than conventional dendritic. Oncoimmunology 2(11):e26859","journal-title":"Oncoimmunology"},{"issue":"3","key":"5403_CR40","doi-asserted-by":"publisher","first-page":"015","DOI":"10.1007\/s12032-015-0499-9","volume":"32","author":"Y Qian","year":"2015","unstructured":"Qian Y, Pei D, Cheng T et al (2015) CD137 ligand-mediated reverse signaling inhibits proliferation and induces. Med Oncol 32(3):015\u20130499","journal-title":"Med Oncol"},{"issue":"5","key":"5403_CR41","first-page":"1197","volume":"15","author":"J Dimberg","year":"2006","unstructured":"Dimberg J, Hugander A, W\u00e5gs\u00e4ter D (2006) Expression of CD137 and CD137 ligand in colorectal cancer patients. Oncol Rep 15(5):1197\u20131200","journal-title":"Oncol Rep"},{"issue":"5","key":"5403_CR42","first-page":"275","volume":"47","author":"G Sica","year":"1999","unstructured":"Sica G, Chen L (1999) Biochemical and immunological characteristics of 4\u20131BB (CD137) receptor and ligand and potential applications in cancer therapy. Arch Immunol Ther Exp 47(5):275\u2013279","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"5403_CR43","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1038\/s41467-021-24767-5","volume":"12","author":"C Geuijen","year":"2021","unstructured":"Geuijen C, Tacken P, Wang LC, Klooster R, van Loo PF, Zhou J, Mondal A, Liu YB, Kramer A, Condamine T, Volgina A (2021) A human CD137\u00d7 PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade. Nat Commun 12(1):4445","journal-title":"Nat Commun"},{"issue":"5","key":"5403_CR44","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.4049\/jimmunol.160.5.2488","volume":"160","author":"J Langstein","year":"1998","unstructured":"Langstein J, Michel J, Fritsche J, Kreutz M et al (1998) CD137 (ILA\/4-1BB), a member of the TNF receptor family, induces monocyte. J Immunol 160(5):2488\u20132494","journal-title":"J Immunol"},{"issue":"8","key":"5403_CR45","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/intimm\/dxl063","volume":"18","author":"LV Fostel","year":"2006","unstructured":"Fostel LV, Dluzniewska J, Shimizu Y et al (2006) ADAP is dispensable for NK cell development and function. Int Immunol 18(8):1305\u20131314","journal-title":"Int Immunol"},{"issue":"7","key":"5403_CR46","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/jth.12966","volume":"13","author":"C Levin","year":"2015","unstructured":"Levin C, Koren A, Pretorius E et al (2015) Deleterious mutation in the FYB gene is associated with congenital autosomal recessive small\u2010platelet thrombocytopenia. J Thromb Haemost 13(7):1285\u20131292","journal-title":"J Thromb Haemost"},{"issue":"30","key":"5403_CR47","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.1073\/pnas.0900510106","volume":"106","author":"H Wang","year":"2009","unstructured":"Wang H, Wei B, Bismuth G et al (2009) SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell. Proc Natl Acad Sci U S A 106(30):12436\u201312441","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"5403_CR48","doi-asserted-by":"publisher","first-page":"28427","DOI":"10.1074\/jbc.274.40.28427","volume":"274","author":"M Veale","year":"1999","unstructured":"Veale M, Raab M, Li Z, da Silva AJ, Kraeft SK, Weremowicz S, Morton CC, Rudd CE (1999) Novel isoform of lymphoid adaptor FYN-T-binding protein (FYB-130) interacts with SLP-76 and up-regulates interleukin 2 production. J Biol Chem 274(40):28427\u201328435","journal-title":"J Biol Chem"},{"key":"5403_CR49","doi-asserted-by":"publisher","first-page":"1192838","DOI":"10.3389\/fimmu.2023.1192838","volume":"14","author":"C Liu","year":"2023","unstructured":"Liu C, Raab M, Gui Y, Rudd CE (2023) Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells. Front Immunol 14:1192838","journal-title":"Front Immunol"},{"issue":"2","key":"5403_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1538-7836.2011.04567.x","volume":"10","author":"GE Jarvis","year":"2012","unstructured":"Jarvis GE, Bihan D, Hamaia S et al (2012) A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin \u03b12\u03b21. J Thromb Haemost 10(2):268\u2013277","journal-title":"J Thromb Haemost"},{"issue":"20","key":"5403_CR51","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1182\/blood-2013-08-520627","volume":"123","author":"A Kasirer-Friede","year":"2014","unstructured":"Kasirer-Friede A, Kang J, Kahner B et al (2014) ADAP interactions with talin and kindlin promote platelet integrin \u03b1IIb\u03b23. Blood 123(20):3156\u20133165","journal-title":"Blood"},{"key":"5403_CR52","doi-asserted-by":"publisher","first-page":"8864436","DOI":"10.1155\/2021\/8864436","volume":"30","author":"X Zhang","year":"2021","unstructured":"Zhang X, Shi X, Zhao H et al (2021) Identification and validation of a tumor microenvironment-related gene signature. Biomed Res Int 30:8864436","journal-title":"Biomed Res Int"},{"issue":"1","key":"5403_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/genes13010035","volume":"13","author":"Y Hou","year":"2021","unstructured":"Hou Y, Gratz HP, Ure\u00f1a-Bail\u00e9n G et al (2021) Somatic reversion of a novel IL2RG mutation resulting in atypical X-linked. Genes 13(1):35","journal-title":"Genes"},{"key":"5403_CR54","doi-asserted-by":"publisher","first-page":"1341236","DOI":"10.3389\/fcimb.2024.1341236","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Liao Y, Zhu Z et al (2024) Assistance of next-generation sequencing for diagnosis of disseminated Bacillus. Front Cell Infect Microbiol 14:1341236","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5403_CR55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5114\/ceji.2024.142340","volume":"49","author":"F Cao","year":"2024","unstructured":"Cao F, Shi Y, Deng F, Yan Y (2024) Novel IL2RG gene mutation causing primary combined immunodeficiency disease: a case report and literature review. Cent Eur J Immunol 49(1):300\u2013307","journal-title":"Cent Eur J Immunol"},{"issue":"2","key":"5403_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/acscentsci.8b00688","volume":"5","author":"X Liu","year":"2019","unstructured":"Liu X, Wang B, Li Y, Hu Y, Li X, Yu T, Ju Y, Sun T, Gao X, Wei Y (2019) Powerful anticolon tumor effect of targeted gene immunotherapy using folate-modified nanoparticle delivery of CCL19 to activate the immune system. ACS Cent Sci 5(2):277\u2013289","journal-title":"ACS Cent Sci"},{"issue":"2","key":"5403_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cei\/uxab039","volume":"207","author":"AG Shabgah","year":"2022","unstructured":"Shabgah AG, Al-Obaidi ZMJ, Rahman HS et al (2022) Does CCL19 act as a double-edged sword in cancer development? Clin Exp Immunol 207(2):164\u2013175","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"5403_CR58","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00535-021-01799-8","volume":"56","author":"Y Yan","year":"2021","unstructured":"Yan Y, Zhao W, Liu W et al (2021) CCL19 enhances CD8(+) T-cell responses and accelerates HBV clearance. J Gastroenterol 56(8):769\u2013785","journal-title":"J Gastroenterol"},{"issue":"21","key":"5403_CR59","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.18632\/aging.205184","volume":"15","author":"Gu Qiang","year":"2023","unstructured":"Qiang Gu, Zhou S, Chen C et al (2023) CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment. Aging 15(21):12369\u201312387","journal-title":"Aging"},{"issue":"2","key":"5403_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","volume":"7","author":"R Mazzucchelli","year":"2007","unstructured":"Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7(2):144\u2013154","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5403_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nri3570","volume":"14","author":"MR Clark","year":"2014","unstructured":"Clark MR, Mandal M, Ochiai K et al (2014) Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B. Nat Rev Immunol 14(2):69\u201380","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"5403_CR62","doi-asserted-by":"publisher","DOI":"10.1242\/dev.176180","volume":"146","author":"GA Leung","year":"2019","unstructured":"Leung GA, Cool T, Valencia CH et al (2019) The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident. Development 146(14):176180","journal-title":"Development"},{"issue":"7","key":"5403_CR63","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.4049\/jimmunol.169.7.3752","volume":"169","author":"B Seddon","year":"2002","unstructured":"Seddon B, Zamoyska R (2002) TCR and IL-7 receptor signals can operate independently or synergize to promote. J Immunol 169(7):3752\u20133759","journal-title":"J Immunol"},{"issue":"99","key":"5403_CR64","doi-asserted-by":"publisher","first-page":"eadi3487","DOI":"10.1126\/sciimmunol.adi3487","volume":"9","author":"DM Morgan","year":"2024","unstructured":"Morgan DM, Horton BL, Bhandarkar V et al (2024) Expansion of tumor-reactive CD8(+) T cell clonotypes occurs in the spleen in response to immune checkpoint blockade. Sci Immunol 9(99):eadi3487","journal-title":"Sci Immunol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05403-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05403-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05403-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T11:02:59Z","timestamp":1771066979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05403-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5403"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05403-y","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}